Brain Tumor and Neuro-Oncology Center - Cleveland Clinic

2008 ANNUAL REPORT
Appendix B – Publications
Journal Publications
Angelov L. Stereotactic spine radiosurgery. Spinal Column
2008 Spring;14-15.
Bain M, Moheet AM, Rasmussen P. Which patients benefit
from carotid stenting? What recent trials show. Cleve Clin J
Med 2008 Oct;75(10):714-720.
Balmaceda C, Peereboom D, Pannullo S, Cheung YKK, Fisher
PG, Alavi J, Sisti M, Chen J, Fine RL. Multi-institutional phase
II study of temozolomide administered twice daily in the
treatment of recurrent high-grade gliomas. Cancer 2008 Mar
1;112(5):1139-1146.
Brat DJ, Parisi JE, Kleinschmidt-Demasters BK, Yachnis AT,
Montine TJ, Boyer PJ, Powell SZ, Prayson RA, McLendon
RE. Surgical neuropathology update: a review of changes
introduced by the WHO classification of tumours of the central
nervous system, 4th edition. Arch Pathol Lab Med 2008
Jun;132(6):993-1007.
Brat DJ, Prayson RA, Ryken TC, Olson JJ. Diagnosis of
malignant glioma: role of neuropathology. J Neurooncol 2008
Sep;89(3):287-311.
Buatti J, Ryken TC, Smith MC, Sneed P, Suh JH, Mehta
M, Olson JJ. Radiation therapy of pathologically confirmed
newly diagnosed glioblastoma in adults. J Neurooncol 2008
Sep;89(3):313-337.
Chamberlain WA, Prayson RA. Focal cortical dysplasia type II
(malformations of cortical development) aberrantly expresses
apoptotic proteins. Appl Immunohistochem Mol Morphol 2008
Oct;16(5):471-476.
Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil
RJ, Neyman G, Reuther AM, Suh JH. Salvage stereotactic
radiosurgery effectively treats recurrences from whole-brain
radiation therapy. Cancer 2008 Oct 15;113(8):2198-2204.
Daneshvar H, Nelms J, Muhammad O, Jackson H, Tkach J,
Davros W, Peterson T, Vogelbaum MA, Bruchez MP, Toms SA.
Imaging characteristics of zinc sulfide shell, cadmium telluride
core quantum dots. Nanomed 2008 Feb;3(1):21-29.
Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman
P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS.
Renal cell carcinoma tumors induce T cell apoptosis through
receptor-dependent and receptor-independent pathways. J
Immunol 2008 Apr 1;180(7):4687-4696.
Das T, Sa G, Hilston C, Kudo D, Rayman P, Biswas K, Molto L,
Bukowski R, Rini B, Finke JH, Tannenbaum C. GM1 and tumor
necrosis factor-alpha, overexpressed in renal cell carcinoma,
synergize to induce T-cell apoptosis. Cancer Res 2008 Mar
15;68(6):2014-2023.
Elkassabany NM, Bhatia J, Deogaonkar A, Barnett GH, Lotto
M, Maurtua M, Ebrahim Z, Schubert A, Ference S, Farag E.
Perioperative complications of blood brain barrier disruption
under general anesthesia: a retrospective review. J Neurosurg
Anesthesiol 2008 Jan;20(1):45-48.
Finke JH, Goel M. T-cell unresponsiveness in renal cell
carcinoma patients. In: Bukowski RM, Novick AC, eds. Clinical
management of renal tumors. Totowa, NJ: Humana Press;
2008. Chapter 7. p. 115-130.
Finke JH, Rini B, Ireland J, Rayman P, Richmond A, Golshayan
A, Wood L, Elson P, Garcia J, Dreicer R, Bukowski R. Sunitinib
reverses type-1 immune suppression and decreases T-regulatory
cells in renal cell carcinoma patients. Clin Cancer Res 2008
Oct 15;14(20):6674-6682.
Fitzgerald DP, Palmieri D, Hua E, Hargrave E, Herring JM,
Qian Y, Vega-Valle E, Weil RJ, Stark AM, Vortmeyer AO,
Steeg PS. Reactive glia are recruited by highly proliferative
brain metastases of breast cancer and promote tumor cell
colonization. Clin Exp Metastasis 2008;25(7):799-810.
Fu P, van Heeckeren WJ, Wadhwa PD, Bajor DJ, Creger RJ, Xu
Z, Cooper BW, Laughlin MJ, Gerson SL, Koc ON, Lazarus HM.
Time-dependent effect of non-Hodgkin’s lymphoma grade on
disease-free survival of relapsed/refractory patients treated with
high-dose chemotherapy plus autotransplantation. Contemp
Clin Trials 2008 Mar;29(2):157-164.
George S, Hutson TE, Mekhail T, Wood L, Finke J, Elson
P, Dreicer R, Bukowski RM. Phase I trial of PEG-interferon
and recombinant IL-2 in patients with metastatic renal
cell carcinoma. Cancer Chemother Pharmacol 2008
Jul;62(2):347-354.
Georgitsi M, De Menis E, Cannavo S, Makinen MJ, Tuppurainen
K, Pauletto P, Curto L, Weil RJ, Paschke R, Zielinski G,
Wasik A, Lubinski J, Vahteristo P, Karhu A, Aaltonen LA. Aryl
hydrocarbon receptor interacting protein (AIP) gene mutation
analysis in children and adolescents with sporadic pituitary
adenomas. Clin Endocrinol (Oxf ) 2008 Oct;69(4):621-627.
Gibson SE, Zeng WF, Weil RJ, Prayson RA. Aurora B kinase
expression in ependymal neoplasms. Appl Immunohistochem
Mol Morphol 2008 May;16(3):274-278.
Grossman SA, Carson KA, Phuphanich S, Batchelor T,
Peereboom D, Nabors LB, Lesser G, Hausheer F, Supko
JG. Phase I and pharmacokinetic study of karenitecin in
patients with recurrent malignant gliomas. Neuro Oncol
2008 Aug;10(4):608-616.
37